AMOXIL
AMOXICILLIN
Approval overview AMOXIL is listed in Drugs@FDA under application 050460 (NDA).
Review priority: PRIORITY Marketing status: Discontinued Active ingredient AMOXICILLIN Form and strength FOR SUSPENSION;ORAL - 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 1974-01-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview AMOXIL is listed in Drugs@FDA under application 050460 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient AMOXICILLIN Form and strength FOR SUSPENSION;ORAL - 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 1974-01-18 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.